Register
Login:
Share:
Email Facebook Twitter

EXCLUSIVE: Oil analyst Barney Gray discusses the latest from Tower, Coro, Colter, Reabold & United Watch Here

EXCLUSIVE: Oil analyst Barney Gray discusses the latest from Tower, Coro, Colter, Reabold & United
UPDATE: #COPL set timeline for Q2/Q3 Nigeria drilling programme


Media

Cabot Energy #CAB strikes a transformational deal in Canada with i-Pulse

Cabot Energy, listed on AIM as #CAB, have bought the remaining 25% of the oil-producing Canadian assets they operate in Alberta. In effect they become the operator of the field and all revenues ...

Understanding 2018 markets with brokers London Stone Securities

Ranjeet Singh, Director at brokers London Stone Securities, and himself a long term investor, gives us his six monthly market update. Ranjeet discusses his investment trends for 2018 and tell us ...

EXCLUSIVE: HemoGenyx are creating blood cancer treatments with US$9 billion market potential

#HEMO are a London-listed, US-based biotech company developing two revolutionary blood cancer treatments. CDX antibodies are intended to remove the need for chemo and radiation before a bone marrow ...

RNS VIDEO: Reabold Resources #RBD raise £6M and take stake in Danube Petroleum

Reabold Resources Co-Chief Executives Stephen Williams and Sachin Oza have just successfully raised 'approximately six million pounds' to invest in their innovative strategy. #RBD have also today ...

#PHARMA: Therapix Biosciences are developing 'medicinal cannabis' for Tourette's and sleep apnea

Josh Blacher, CFO at Therapix Biosciences, describes how his company are developing a therapeutic approach to obstructive sleep apnea, and in parallel are developing a synthetic cannabinoid-based ...

#PHARMA: Quantum Genomics to launch new class of high blood pressure drug

Lionel Segard is Chairman & CEO of Quantum Genomics, a French biotech company launched 11 years ago. Quantam are developing 1st in class drugs to treat hypertension and chronic heart ...

#PHARMA: Want to invest in PDL, the 'new Berkshire Hathaway' for Health Care?

Peter Garcia, the CFO at PDL BioPharma explains that in his view, PDL is 'unique'. Located in Lake Tahoe, Nevada, PDL is a publicly traded private equity group listed on Nasdaq: #PDLI. 'PDL allows ...

#PHARMA: NeuroVive are groundbreaking specialists in mitochondrial treatments

Erik Kinnman, CEO of Swedish biotech company NeuroVive Pharmaceutical, says that his company are at the forefront of research into mitochondrial medicine, which is the subject of growing ...

#PHARMA: Volition expects to market 'revolutionary' colo-rectal cancer blood test Q3 2018

Cameron Reynolds, Volition CEO, told London South East he expects to hit significant clinical test milestones in 2018 and to get a CE Mark and to begin selling their colorectal cancer blood test in ...

#PHARMA: Race Oncology has a successful track record of profitably recycling old drugs

Peter Molloy, CEO at Race Oncology explains how his business speeds up taking drugs to market. Race look for old drug assets which have been developed and discarded by big pharma companies who chose ...



Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.